Skip to main content

Juul Fails To Block Vaping Products Trial

Juul Fails To Block Vaping Products Trial

Juul Fails To Block Vaping Products Trial

Introduction

JuuL Labs Inc. has failed to block the first trial from 2,500 personal injury cases against the e-cigarette maker, which accuses the company of marketing vaping products targeting minors.

As per the court documents, a Tennessee woman alleged that her daughter developed an addiction to using the company's vaping products at the age of 12. The company requested the court to dismiss the claims in the lawsuit, but U.S. District Judge William Orrick rejected the company's plea.

The company stated in its defense that the claims are meritless as the teen failed to identify any specific advertisement which encouraged her to use the JuuL products. The court filings of the company even notified that bright colors and young models, which were used to promote the products were just an exaggerated marketing strategy  which should not be taken seriously.

In 2020, the legal problems for Juul increased after a 39-state probe was announced into its teen marketing. The company's popularity increased, resulting in domination of the e-cigarette market. The success eventually brought the company into limelight which was noticed by the federal regulators and state attorneys general who were concerned about the impact of the products on teenagers.

JuuL will face six bellwether trials which allege that the company used illegal marketing strategies and targeted minors to boost their sale resulting in nicotine addiction among the youths. The first bellwether trial is scheduled to start on June 16.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Links Roundup Chemical to Long-Term Brain Damage

Categories: Roundup

A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…

Zimmer Biomet Gets FDA Approval for Cementless Partial Knee

Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…

Court Names Special Masters for Bard Mesh Claim Settlements

Categories: Hernia Mesh

The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!